Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.
Pfizer
Pfizer
Bristol-Myers Squibb
Seoul St. Mary's Hospital
Multiple Myeloma Research Foundation
Regeneron Pharmaceuticals
Celgene
CARsgen Therapeutics Co., Ltd.
Duke University
AbbVie
University of California, San Francisco
Bristol-Myers Squibb
Centre Hospitalier Universitaire de Saint Etienne
Celgene
Rutgers, The State University of New Jersey
Genesis Pharma S.A.
PETHEMA Foundation
Celgene
Vanderbilt-Ingram Cancer Center
Vanderbilt University Medical Center
Karolinska University Hospital
Columbia University
Mayo Clinic
Vanderbilt-Ingram Cancer Center